AllianceBernstein’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$489K Hold
39,850
﹤0.01% 2647
2025
Q4
$489K Hold
39,850
﹤0.01% 2669
2025
Q3
$817K Hold
39,850
﹤0.01% 2445
2025
Q2
$538K Buy
39,850
+12,800
+47% +$140K ﹤0.01% 2602
2025
Q1
$234K Hold
27,050
﹤0.01% 2875
2024
Q4
$131K Hold
27,050
﹤0.01% 3096
2024
Q3
$209K Hold
27,050
﹤0.01% 3029
2024
Q2
$271K Buy
27,050
+2,850
+12% +$31.3K ﹤0.01% 2950
2024
Q1
$294K Sell
24,200
-1,500
-6% -$21.8K ﹤0.01% 2802
2023
Q4
$368K Hold
25,700
﹤0.01% 2757
2023
Q3
$200K Hold
25,700
﹤0.01% 2964
2023
Q2
$367K Buy
25,700
+2,459
+11% +$35K ﹤0.01% 2780
2023
Q1
$340K Sell
23,241
-2,490
-10% -$41.7K ﹤0.01% 2727
2022
Q4
$432K Buy
25,731
+3,987
+18% +$68.9K ﹤0.01% 2702
2022
Q3
$322K Buy
21,744
+2,105
+11% +$41.6K ﹤0.01% 2833
2022
Q2
$538K Buy
19,639
+80
+0.4% +$2.37K ﹤0.01% 2651
2022
Q1
$738K Buy
19,559
+25
+0.1% +$1.11K ﹤0.01% 2528
2021
Q4
$1.21M Buy
19,534
+2,534
+15% +$192K ﹤0.01% 2384
2021
Q3
$1.45M Hold
17,000
﹤0.01% 2343
2021
Q2
$1.05M Buy
+17,000
New +$865K ﹤0.01% 2513
2021
Q1
Sell
-8,100
Closed -$252K 3286
2020
Q4
$252K Buy
+8,100
New +$198K ﹤0.01% 2928

Other funds holding OPRX

AllianceBernstein's OPRX Position: Q1 2026 in Review

AllianceBernstein held its OptimizeRx (OPRX) position steady in Q1 2026 at 39,850 shares worth $489K. The position accounts for ﹤0.01% of the portfolio, ranked #2647.

AllianceBernstein first reported a position in OPRX in Q4 2020 and has held it in 21 quarters since. The position peaked at $1.45M in Q3 2021. 128 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.

  • AllianceBernstein held 39,850 shares of OptimizeRx worth $489K as of Q1 2026.
  • AllianceBernstein left its OptimizeRx share count unchanged in Q1 2026.
  • OptimizeRx made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #2647 holding.
  • AllianceBernstein first reported a position in OptimizeRx in Q4 2020 and has held it in 21 quarters since.
  • AllianceBernstein's OptimizeRx position peaked at $1.45M in Q3 2021.
  • 128 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.